Improving effect of dietary soybean phospholipids supplement on hepatic and serum indexes relevant to fatty liver hemorrhagic syndrome in laying hens. (5th July 2017)

• Record Type: Journal Article
• Authors: Yang, Fei; Ruan, Jiming; Wang, Tiancheng; Luo, Junrong; Cao, Huabin; Song, Yalu; Huang, Jianzhen; Hu, Guoliang
• Is Part Of: Animal science journal. Volume 88:Number 11(2017:Nov.)
• Page Start: 1860
• Page End: 1869
• Publication Date: 2017-07-05
• Subjects: fatty liver hemorrhagic syndrome -- high‐energy‐low‐protein diet -- laying hens -- soybean phospholipids supplement; Animal culture -- Periodicals; Livestock -- Periodicals; 636
• DOI: 10.1111/asj.12832
• Languages: English
• ISSNs: 1344-3941

Abstract

Abstract: In order to investigate the effect of dietary soybean phospholipid supplement on hepatic and serum indexes relevant to fatty liver hemorrhagic syndrome (FLHS) in layers, 135 300‐day‐old Hyline Brown layers were randomly divided into three groups (control, pathology and prevention), and each group had 45 layers with three replicates. Birds in the three groups were respectively fed the control diet, high‐energy low‐protein diet and high‐energy high‐protein diet affixed with 3% soybean phospholipid instead of maize. Results showed in the 30th day, birds' livers in the pathology group became yellowish, enlarged in size and had hemorrhagic spots, while the prevention and control groups' layers did not have such pathological changes. Contents of triglyceride, total cholesterol, low‐density lipoprotein – cholesterol, non‐esterified fatty acid and malondialdehyde in serum or liver homogenate in prevention and control groups were remarkably lower than those in the pathology group ( P < 0.05 or P < 0.01), as with the activities of glutamic oxalacetic transaminase and glutamic‐pyruvic transaminase ( P < 0.01); high‐density lipoprotein – cholesterol value was strikingly higher than that of the pathology group ( P < 0.01). It is suggested dietary soybean phospholipids supplement may effectively improve hepatic and blood indexes relevant to FLHS, which provides a new point for preventing FLHS occurrence rate in laying flocks and treating human non‐alcohol fatty liver disease.